Two Consecutive QC Failures, Twelve Patients Waiting, and a Hematocrit of 61%
A three-room rural clinic holds a CLIA Certificate of Waiver and performs glucose testing only on a waived meter; three medical assistants rotate through testing. A new lot of strips arrives and the morning QC gives Level 1 = 98 mg/dL (acceptable 80–120) and Level 2 = 212 mg/dL (acceptable 240–300). The MA repeats Level 2 once and gets 218 mg/dL. She reports that Level 1 was fine, the Level 2 gap is 'only about 30 points,' and twelve patients are waiting - she intends to start testing. One of those patients is a 74-year-old with COPD whose last hematocrit was 61%, and who is first on the list because he is 'always a little hypoglycemic.' A second MA was hired four months ago and has never had a documented competency assessment.
1. What do you do about the Level 2 failure and the twelve waiting patients?
Read the worked answer
Testing stops for that system. QC is judged against the manufacturer's published range, not against 'close enough,' and two consecutive out-of-range Level 2 results are an out-of-control event. Patient results produced on a system with failed QC are not reportable, because the failure gives no assurance the values are wrong in a predictable direction - a strip-lot or calibration problem can bias every result at the clinical decision points that matter (hypoglycemia, insulin dosing).
Troubleshoot systematically, in the order that eliminates causes fastest: strip expiration and storage (desiccant, cap left off, heat), lot/code entry on the meter, control solution expiration and handling (was it frozen, was it properly mixed), meter cleanliness and battery, ambient temperature.
While troubleshooting: switch to the backup meter only after its own QC passes on the new lot, or send the urgent samples to the reference lab; call the lab director or designee, document the failure and each corrective action, and notify the clinic leadership. Resume only after QC passes and the corrective action is recorded. A patient who genuinely needs a glucose now gets a result from a verified method, not a guess from an unverified one.
2. The COPD patient's meter glucose reads 44 mg/dL, but he is awake, conversant, and asymptomatic. What do you do?
Read the worked answer
Treat the patient and doubt the number at the same time.
First the safety step: a reported glucose of 44 is in critical-value territory, so you cannot simply shrug it off - assess for symptoms (he has none), keep him in the chair, and get a confirmatory result from a method that is valid for his hematocrit, either a lab plasma glucose or a second device whose validated hematocrit range includes 61%.
Second, the technical step: meter performance is validated only within a specified hematocrit range (commonly something like 30–55%, per the manufacturer's labeling). At 61% his result falls outside the validated range, and the bias is unpredictable in magnitude although high hematocrit tends to bias many systems low. That bias direction is precisely why a falsely low value in an asymptomatic patient is the expected presentation, and also why you must not conclude 'he's fine' without a confirmatory test.
Third, the follow-through: notify the provider with both values and the caveat, document the interference and the hematocrit, and flag his record so future glucose testing is done by a method valid at his hematocrit rather than by meter default. Do not report a critical value from an out-of-range specimen as though it were a lab-verified result; state what it is.
3. The MA hired four months ago has no documented competency assessment. What does the waived status require, and what does the inspection 18 months ago have to do with it?
Read the worked answer
Waived status relaxes the requirement for a formal quality-control program, not the requirement for competent operators. Under CLIA, personnel performing waived testing must have documented training and competency assessment: semiannually during the first year of testing and annually thereafter, covering the six elements - direct observation of patient testing, direct observation of instrument maintenance, review of the operator's recorded results, assessment of test performance, assessment of problem-solving, and review of QC and maintenance records.
At four months she is due for her first semiannual assessment, and she should not be performing unsupervised patient testing until at least her initial training/competency is documented. The most common inspection finding in waived sites is exactly this gap - a folder of annual assessments with a new hire's missing first-year six-month check.
The 18-month inspection gap is a separate lesson: Certificate of Waiver labs still must be available for inspection, follow the manufacturer's instructions, and be able to produce personnel and QC records on request. Because on-site visits are infrequent, the documentation has to be right all the time, not right on inspection week. Audit the personnel file for all three MAs and schedule the missing assessment before the next patient is tested.